Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD
August 15, 2024 07:45 ET
|
Cingulate Inc.
KANSAS CITY, Kan., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Willo Introduces Several New Product Enhancements to its Industry Leading Locking System, the Willo Wedge™
August 14, 2024 11:00 ET
|
Willo Products Company
Willo Products Company, LLC announces the launch of the next generation of its revolutionary swinging door locking system platform.
Medsenic reçoit l'intention de délivrer un brevet européen clé de l'OEB, précieux pour le développement thérapeutique du trioxyde d'arsenic dans la sclérose en plaques récurrente-rémittente.
August 14, 2024 01:00 ET
|
BioSenic
INFORMATION PRIVILEGIEE Le médicament de Medsenic, le trioxyde d'arsenic, peut maintenant être étudié pour le traitement de la sclérose en plaques par des cycles répétés d'administration par de...
Medsenic receives the intention to grant a key European patent from EPO, valuable for the therapeutic development of arsenic trioxide in relapsing-remitting multiple sclerosis
August 14, 2024 01:00 ET
|
BioSenic
INSIDE INFORMATION Medsenic's experimental drug, arsenic trioxide, can now be investigated for the treatment of multiple sclerosis through repeated cycles of administration by multiple routes,...
Le brevet de Medsenic/BioSenic est accordé au Japon pour plus de protection de sa plate-forme thérapeutique
August 13, 2024 12:00 ET
|
BioSenic
INFOMATION PRIVILEGIEE Le brevet sur la composition de la matière couvre l'utilisation thérapeutique des sels d'arsenic et des ions métalliques par diverses voies d'administration.Le portefeuille...
Medsenic/BioSenic patent granted in Japan for more protection of its therapeutic platform
August 13, 2024 12:00 ET
|
BioSenic
PRIVILEGED INFORMATION Composition-of-matter patent covers the therapeutic use of arsenic salts and metal ions through various routes of administration.Enriched IP portfolio protects arsenic...
Mobiquity Technologies Partners with Context Networks to Transform Slot Machine Advertising in Casinos
August 13, 2024 08:45 ET
|
Mobiquity Technologies, Inc.
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (OTC: MOBQ), a leading provider of next-generation data intelligence and advertising technology solutions, proudly announces...
Neurotech Innovation Achieves Patent Approval and Featured Cover Story in Prominent Industry Journal
August 09, 2024 09:00 ET
|
Longeviti Neuro Solutions
Longeviti, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, announced its patent for its ClearFit Implant.
OKYO Pharma Granted European Patent Covering OK-101 Chemerin Analogs and Their Method of Use
August 06, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Molekule, Inc. secures patent for revolutionary coating removal technology funded by DOD’s SERDP agency
July 22, 2024 08:00 ET
|
Molekule
PALM BEACH GARDENS, Fla., July 22, 2024 (GLOBE NEWSWIRE) -- Molekule, a leader in air purification technology, proudly announces the approval of its patent (US-11,998,958) for an innovative...